GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease

Autor: M. Billon-Grand, Robin Cloarec, Laurie-Anne Gouty-Colomer, N. Oumar, Amandine Dufour, Alexandre Pons-Bennaceur, Constance Hammond, Yehezkel Ben-Ari, Sanaz Eftekhari, Baptiste Riffault, Nail Burnashev, Natalia Lozovaya
Přispěvatelé: ISARA-Lyon, Institut de Neurobiologie de la Méditerranée [Aix-Marseille Université] (INMED - INSERM U1249), Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), PRA, Fanny
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Patch-Clamp Techniques
Vesicular Inhibitory Amino Acid Transport Proteins
Dopamine
striatum
Parkinson's disease
Cholinergic Agents
Action Potentials
General Physics and Astronomy
Mice
0302 clinical medicine
Sodium Potassium Chloride Symporter Inhibitors
Solute Carrier Family 12
Member 2

lcsh:Science
Bumetanide
gamma-Aminobutyric Acid
Neuronal Plasticity
Multidisciplinary
Glutamate Decarboxylase
Chemistry
GABA polarity
Cholinergic Neurons
3. Good health
Parkinson disease
ACh/GABA cotransmission
Excitatory postsynaptic potential
GABAergic
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
medicine.drug
Science
LIM-Homeodomain Proteins
Mice
Transgenic

Nerve Tissue Proteins
Inhibitory postsynaptic potential
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Chlorides
Interneurons
medicine
Animals
Humans
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Patch clamp
Parkinson Disease
Secondary

Ion Transport
Antagonist
General Chemistry
Microreview
Acetylcholine
Corpus Striatum
Cellular neuroscience
nervous system diseases
030104 developmental biology
Gene Expression Regulation
Inhibitory Postsynaptic Potentials
nervous system
Cholinergic
lcsh:Q
Neuroscience
030217 neurology & neurosurgery
Transcription Factors
Zdroj: Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
Nature Communications
Nature Communications, Nature Publishing Group, 2018, 9 (1), ⟨10.1038/s41467-018-03802-y⟩
Cell Stress
ISSN: 2041-1723
DOI: 10.1038/s41467-018-03802-y⟩
Popis: The rule of one terminal and one transmitter acting on one synapse clearly fails to cover the complexity of chemical synapse operation in the brain. Compelling evidence now indicates that two transmitters can be released from the same terminal, acting in a complementary manner to generate complex electrical activity in the targets. Our laboratory now showed that a subpopulation striatal cholinergic neurons also release the classical inhibitory transmitter GABA with a balance between excitation and inhibition being provided by acetylcholine and GABA, respectively. An illustration of the importance of this dual release comes from the fact that when dopamine signals are absent such as in Parkinson disease (PD) the GABAergic inhibition in these dual cholinergic/GABAergic cells fails because of high intracellular chloride ((Cl-)I) levels rendering the cholinergic excitatory component unmet by a parallel inhibitory drive. Restoring low (Cl-)I with the NKCC1 chloride importer antagonist bumetanide attenuates the electrical and motor disturbance. In addition to illustrating the complex interactions between two transmitters acting at the same synapse, this study paves the way to novel conceptual treatment of PD based on restoration of GABAergic inhibition in keeping with our pilot clinical trial showing indeed that bumetanide together with levodopa attenuates axial motor disturbance. It is also in keeping with extensive investigations showing increased (Cl-)I levels and weakened inhibition in a wide range of pathological insults and their restoration by bumetanide. It raises fundamental issues related to the operation of the striatum and basal ganglia in health and disease.
Databáze: OpenAIRE